pharma · Advanced Solid Tumor · Hepatocellular Carcinoma
Coherus Oncology
Coherus Oncology is a pharma organization headquartered in Redwood City, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Hepatocellular Carcinoma, Rheumatoid Arthritis, Plaque Psoriasis, Metastatic Sol
333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US HQ
2010 Founded
212 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
- Founded
- 2010
- Employees
- 212
- Programs
- 25
- Drugs
- 11
- Patents
- 73
NY-ESO-1 Peptide vaccine
Phase 2 · mab · Ovarian Cancer Stage IV
NY-ESO-1 Peptide vaccine for Ovarian Cancer Stage IV is a Phase 2 program (mab) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Internal code STUDY00005324
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Coherus Oncology
- Phase
- Phase 2
- Modality
- mab
- Indication
- Ovarian Cancer Stage IV
- Status
- active
- Trials
- 1